BCR-ABL1 Mutation Analysis tests in Dubai & UAE

Compare available BCR-ABL1 Mutation Analysis tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,500.00–2,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

BCR-ABL1 Mutation Analysis test prices

Showing 1–2 of 2 matching tests.

BCR-ABL1 Mutation Analysis diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1823 BCR-ABL1 Kinase Domain Mutation Analysis (NGS) Test This test identifies mutations in the BCR-ABL1 gene associated with resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia (CML).	Peripheral blood (preferred) or bone marrow aspirate	14–21 days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Variant Allele Fraction (VAF)"] Parameters [] Preparation ["No specific drug washout is needed.", "Peripheral blood should be drawn immediately before the next scheduled TKI dose (if applicable)."] Indications ["Monitoring treatment response in CML patients on TKI therapy", "Identifying resistance mutations to guide TKI selection", "Evaluating patients with suspected TKI resistance"] Measurement technique Confirm with laboratory Codes LOINC: 30504-1 ICD-10: C92.1 Clinical summary This test identifies mutations in the BCR-ABL1 gene associated with resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia (CML).
TEST-1827 BCR-ABL1 Kinase Domain Mutation Analysis Test This test identifies specific mutations in the BCR-ABL1 gene that confer resistance to tyrosine kinase inhibitor therapy in CML patients.	Peripheral blood (whole blood) or Bone marrow aspirate	7–8 business days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Resistance to tyrosine kinase inhibitors"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Monitoring CML treatment response", "Guiding selection of next-generation TKIs", "Identifying resistance mechanisms"] Measurement technique Confirm with laboratory Codes LOINC: 92836-6 ICD-10: C92.1 Clinical summary This test identifies specific mutations in the BCR-ABL1 gene that confer resistance to tyrosine kinase inhibitor therapy in CML patients.

Category overview

BCR-ABL1 Mutation Analysis: overview

When standard leukemia therapies stop working, securing an accurate molecular profile of your condition offers invaluable peace of mind and a renewed direction for care. As part of our Molecular Diagnostics division, our BCR-ABL1 Mutation Analysis employs cutting-edge DNA sequencing to evaluate specific resistance markers within the leukemia fusion gene. Rather than providing an isolated clinical diagnosis, this essential BCR-ABL1 mutation analysis data serves as a vital tool for your hematologist, shaping highly targeted, alternative medical guidance and therapy adjustments. Trusted as one of the leading diagnostic labs in the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality and consistently rapid, precise turnaround times. Take a proactive step for your ongoing oncology wellness: review our BCR-ABL1 mutation analysis in the UAE below to book an appointment, schedule a gentle home collection, or consult our dedicated experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.